Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urologica e Nefrologica 2018 February;70(1) > Minerva Urologica e Nefrologica 2018 February;70(1):95-101

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   Free accessfree

Minerva Urologica e Nefrologica 2018 February;70(1):95-101

DOI: 10.23736/S0393-2249.17.02869-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Clinical observation of umbilical cord mesenchymal stem cell transplantation for treating patients receiving peritoneal dialysis

Hong-Ying JIANG 1, Jia-Ping WANG 2, Yi-Hua BAI 1 , Min YANG 1, Yi ZENG 1, Yun-Juan LIAO 1, Zhen-Kun HE 1

1 Department of Nephrology, the Second Hospital Affiliated Kunming Medical University, Kunming, China; 2 Department of Radiology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China


PDF


BACKGROUND: This study aims to observe the outcome and safety of umbilical cord-mesenchymal stem cell (UC-MSC) treatment for continuous ambulatory peritoneal dialysis (CAPD) patients.
METHODS: A total of 24 CAPD patients, who underwent UC-MSC treatment from June 2011 to December 2012, were selected for this study. These patients were followed up until June 2015.
RESULTS: Results revealed a significant increase in hemoglobin, erythropoietin and albumin levels, a decrease in C-reactive protein levels, and marked improvement in cystatin C and urine volume within three months after UC-MSC transplantation; and the difference was statistically significant (P<0.05). However, the difference in residual glomerular filtration rate, serum creatinine, peritoneal KT/V and remnant kidney KT/V was not statistically significant (P>0.05).
CONCLUSIONS: Clinical indicators of patients with CAPD can be partially improved through UC-MSC treatment.


KEY WORDS: Umbilical cord - Mesenchymal stromal cells - Peritoneal dialysis - Therapy - C-reactive protein - Erythropoietin

inizio pagina